SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-19-003852
Filing Date
2019-11-29
Accepted
2019-11-29 09:04:27
Documents
52
Period of Report
2019-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K cannabics_10k-083119.htm 10-K 750251
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, cannabics_ex3101.htm EX-31.1 10462
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, cannabics_ex3102.htm EX-31.2 10677
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cannabics_ex3201.htm EX-32.1 4167
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cannabics_ex3202.htm EX-32.2 4302
6 GRAPHIC image_001.jpg GRAPHIC 108010
  Complete submission text file 0001683168-19-003852.txt   2600905

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cnbx-20190831.xml EX-101.INS 326333
8 XBRL SCHEMA FILE cnbx-20190831.xsd EX-101.SCH 22657
9 XBRL CALCULATION FILE cnbx-20190831_cal.xml EX-101.CAL 41915
10 XBRL DEFINITION FILE cnbx-20190831_def.xml EX-101.DEF 65951
11 XBRL LABEL FILE cnbx-20190831_lab.xml EX-101.LAB 175521
12 XBRL PRESENTATION FILE cnbx-20190831_pre.xml EX-101.PRE 141056
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
Cannabics Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 000-52403 | Film No.: 191259913
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences